Dynamic contrast enhanced (DCE-) MRI is widely acquired as a part of neuroimaging protocol for evaluation of glioblastoma tumors before the start of therapy or monitoring and assessment of treatment response in longitudinal scans. Nonetheless, lack of a standardized quantification method has limited its application in clinical settings, multi-institutional studies and clinical trials. These challenges have motivated efforts to validate DCE-MRI using benchmark biomedical image analysis methods. The Open-Source Initiative for Perfusion Imaging (OSIPI) has designed the OSIPI-DCE challenge to evaluate and compare DCE tools in terms of accuracy, repeatability, and reproducibility of Ktrans estimation in the brain.
This abstract and the presentation materials are available to members only; a login is required.